Trgovina Indivior PLC - INDV CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 0.1190 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.028007% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | -0.015829% | ||||||||
| Čas nočne pristojbine | 22:00 (UTC) | ||||||||
| Min. tržena količina | 0.1 | ||||||||
| Valuta | GBP | ||||||||
| Kritje | 20% | ||||||||
| Borza | United Kingdom of Great Britain and Northern Ireland | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Indivior PLC ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Ključni statistični podatki
| Predhodno. Zapri* | 19.189 |
| Odpri* | 19.049 |
| Enoletna sprememba* | 784.15% |
| Dnevni razpon* | 19.029 - 19.463 |
| Razpon 52 wk | 10.52-20.20 |
| Povprečni obseg (10 dni) | 260.40K |
| Povprečni obseg (3 meseci) | 7.55M |
| Tržna kapitalizacija | 2.65B |
| Razmerje P/E | 20.84 |
| Število delnic v obtoku | 136.25M |
| Prihodki | 734.85M |
| EPS | 0.93 |
| Dividenda (donosnost v %) | N/A |
| Beta | -0.23 |
| Datum naslednjega zaslužka | Feb 16, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| Feb 6, 2023 | 19.3630 | 0.4045 | 2.13% | 18.9585 | 19.4785 | 18.9585 |
| Feb 3, 2023 | 19.1890 | 0.1605 | 0.84% | 19.0285 | 19.3385 | 18.8895 |
| Feb 2, 2023 | 19.0335 | 0.1645 | 0.87% | 18.8690 | 19.1890 | 18.7340 |
| Feb 1, 2023 | 18.9140 | -0.5440 | -2.80% | 19.4580 | 19.6280 | 18.8540 |
| Jan 31, 2023 | 19.4385 | 0.0800 | 0.41% | 19.3585 | 19.5785 | 19.3135 |
| Jan 30, 2023 | 19.6285 | 0.5495 | 2.88% | 19.0790 | 19.6680 | 19.0790 |
| Jan 27, 2023 | 19.4985 | 0.0455 | 0.23% | 19.4530 | 19.5585 | 19.4030 |
| Jan 26, 2023 | 19.5985 | -0.0795 | -0.40% | 19.6780 | 19.8175 | 19.5730 |
| Jan 25, 2023 | 19.6980 | -0.1000 | -0.51% | 19.7980 | 19.8080 | 19.4285 |
| Jan 24, 2023 | 19.7725 | -0.2040 | -1.02% | 19.9765 | 20.1365 | 19.6230 |
| Jan 23, 2023 | 19.9765 | 0.4440 | 2.27% | 19.5325 | 19.9975 | 19.5325 |
| Jan 20, 2023 | 19.9080 | 0.4695 | 2.42% | 19.4385 | 19.9175 | 19.4080 |
| Jan 19, 2023 | 19.6080 | 0.2200 | 1.13% | 19.3880 | 19.7580 | 19.2980 |
| Jan 18, 2023 | 19.3885 | -0.0795 | -0.41% | 19.4680 | 19.6085 | 19.2785 |
| Jan 17, 2023 | 19.5785 | 0.2205 | 1.14% | 19.3580 | 19.7780 | 19.1685 |
| Jan 16, 2023 | 19.3580 | -0.1000 | -0.51% | 19.4580 | 19.5485 | 19.2690 |
| Jan 13, 2023 | 19.4380 | 0.2345 | 1.22% | 19.2035 | 19.4485 | 19.1935 |
| Jan 12, 2023 | 19.1990 | 0.2150 | 1.13% | 18.9840 | 19.2785 | 18.9840 |
| Jan 11, 2023 | 18.9740 | 0.3945 | 2.12% | 18.5795 | 19.1190 | 18.5795 |
| Jan 10, 2023 | 19.0490 | 0.4100 | 2.20% | 18.6390 | 19.3190 | 18.6340 |
Indivior PLC Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Letni
- Četrtletno
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Skupni prihodki | 1058 | 1093 | 1005 | 785 | 647 | 791 |
| Prihodki | 1058 | 1093 | 1005 | 785 | 647 | 791 |
| Celotni stroški prihodkov | 107 | 104 | 128 | 140 | 92 | 127 |
| Bruto dobiček | 951 | 989 | 877 | 645 | 555 | 664 |
| Celotni odhodki iz poslovanja | 909 | 914 | 713 | 609 | 810 | 587 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 669 | 694 | 465 | 371 | 410 | 393 |
| Raziskave in razvoj | 119 | 89 | 67 | 53 | 40 | 52 |
| Depreciation / Amortization | 14 | 13 | 13 | 19 | 17 | 13 |
| Prihodki iz poslovanja | 149 | 179 | 292 | 176 | -163 | 204 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -51 | -42 | -14 | 4 | -8 | -14 |
| Čisti dobiček pred obdavčitvijo | 98 | 137 | 278 | 180 | -173 | 190 |
| Čisti dobiček po davkih | 35 | 73 | 273 | 134 | -148 | 205 |
| Čisti dobiček pred dodatnimi postavkami | 35 | 73 | 273 | 134 | -148 | 205 |
| Čisti dobiček | 35 | 58 | 275 | 134 | -148 | 205 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 35 | 73 | 273 | 134 | -148 | 205 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 35 | 58 | 275 | 134 | -148 | 205 |
| Popravljen čisti dobiček | 35 | 58 | 275 | 134 | -148 | 205 |
| Popravljene ponderirane povprečne delnice | 743.22 | 748.482 | 751.142 | 755.358 | 732.863 | 771.141 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 0.04709 | 0.09753 | 0.36345 | 0.1774 | -0.20195 | 0.26584 |
| Dividends per Share - Common Stock Primary Issue | 0 | |||||
| Popravljen normalizirani dobiček na enoto čistega dobička | 0.39288 | 0.41284 | 0.47395 | 0.20255 | 0.19103 | 0.3203 |
| Nenavadni odhodki (prihodki) | 14 | 40 | 26 | 251 | 2 | |
| Skupaj izredne postavke | -15 | 2 | 0 | |||
| Prilagoditev za redčenje | 0 | |||||
| Drugo, neto | -2 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Skupni prihodki | 180 | 201 | 187 | 223 | 207 |
| Prihodki | 180 | 201 | 187 | 223 | 207 |
| Celotni stroški prihodkov | 32 | 30 | 26 | 39 | 37 |
| Bruto dobiček | 148 | 171 | 161 | 184 | 170 |
| Celotni odhodki iz poslovanja | 123 | 129 | 149 | 178 | 153 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 73 | 74 | 109 | 137 | 106 |
| Raziskave in razvoj | 9 | 13 | 11 | 19 | 8 |
| Depreciation / Amortization | 3 | 4 | 3 | 3 | 3 |
| Nenavadni odhodki (prihodki) | 6 | 8 | 0 | -20 | -1 |
| Prihodki iz poslovanja | 57 | 72 | 38 | 45 | 54 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -4 | -6 | -7 | -5 | -6 |
| Čisti dobiček pred obdavčitvijo | 53 | 66 | 31 | 40 | 48 |
| Čisti dobiček po davkih | 80 | 62 | 27 | 36 | 41 |
| Čisti dobiček pred dodatnimi postavkami | 80 | 62 | 27 | 36 | 41 |
| Čisti dobiček | 80 | 62 | 27 | 36 | 41 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 80 | 62 | 27 | 36 | 41 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 80 | 62 | 27 | 36 | 41 |
| Popravljen čisti dobiček | 80 | 62 | 27 | 36 | 41 |
| Popravljene ponderirane povprečne delnice | 781.344 | 780.34 | 777.124 | 753.192 | 745.024 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 0.10239 | 0.07945 | 0.03474 | 0.0478 | 0.05503 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | 0.15614 | 0.09867 | 0.03474 | 0.01726 | 0.05369 |
- Letni
- Četrtletno
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 990 | 1225 | 1329 | 1360 | 1187 | 1444 |
| Denarna sredstva in kratkoročne naložbe | 692 | 863 | 924 | 1060 | 858 | 1102 |
| Denarna sredstva in ustrezniki | 692 | 863 | 924 | 1060 | 858 | 1102 |
| Celotne terjatve, neto | 245 | 295 | 318 | 204 | 186 | 215 |
| Accounts Receivable - Trade, Net | 205 | 257 | 269 | 192 | 179 | 202 |
| Total Inventory | 41 | 52 | 78 | 73 | 93 | 95 |
| Prepaid Expenses | 12 | 15 | 9 | 23 | 17 | 18 |
| Total Assets | 1209 | 1444 | 1547 | 1652 | 1531 | 1832 |
| Property/Plant/Equipment, Total - Net | 27 | 54 | 57 | 107 | 103 | 95 |
| Property/Plant/Equipment, Total - Gross | 68 | 101 | 109 | 175 | 171 | 169 |
| Accumulated Depreciation, Total | -41 | -47 | -52 | -68 | -68 | -74 |
| Intangibles, Net | 83 | 92 | 84 | 72 | 62 | 82 |
| Other Long Term Assets, Total | 109 | 58 | 44 | 63 | 97 | 127 |
| Total Current Liabilities | 1030 | 854 | 818 | 742 | 599 | 804 |
| Accounts Payable | 33 | 40 | 47 | 39 | 20 | 137 |
| Accrued Expenses | 625 | 625 | 674 | 584 | 504 | 583 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 101 | 5 | 4 | 9 | 12 | 11 |
| Other Current Liabilities, Total | 271 | 184 | 93 | 110 | 63 | 73 |
| Total Liabilities | 1504 | 1647 | 1481 | 1443 | 1449 | 1629 |
| Total Long Term Debt | 434 | 477 | 237 | 284 | 273 | 275 |
| Long Term Debt | 434 | 477 | 237 | 233 | 230 | 239 |
| Other Liabilities, Total | 40 | 316 | 426 | 417 | 577 | 550 |
| Total Equity | -295 | -203 | 66 | 209 | 82 | 203 |
| Common Stock | 72 | 72 | 73 | 73 | 73 | 70 |
| Retained Earnings (Accumulated Deficit) | -345 | -263 | 20 | 154 | 16 | 146 |
| Other Equity, Total | -22 | -14 | -32 | -23 | -13 | -20 |
| Total Liabilities & Shareholders’ Equity | 1209 | 1444 | 1547 | 1652 | 1531 | 1832 |
| Total Common Shares Outstanding | 720.598 | 721.463 | 728.442 | 730.788 | 733.635 | 702.44 |
| Note Receivable - Long Term | 15 | 33 | 50 | 82 | 84 | |
| Additional Paid-In Capital | 2 | 5 | 5 | 6 | 7 | |
| Capital Lease Obligations | 51 | 43 | 36 | |||
| Other Current Assets, Total | 33 | 14 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 1267 | 1292 | 1314 | 1444 | 1263 |
| Denarna sredstva in kratkoročne naložbe | 945 | 1000 | 1005 | 1102 | 939 |
| Denarna sredstva in ustrezniki | 945 | 1000 | 1005 | 1102 | 874 |
| Celotne terjatve, neto | 208 | 178 | 175 | 215 | 208 |
| Accounts Receivable - Trade, Net | 165 | 170 | 175 | 202 | 195 |
| Total Inventory | 91 | 93 | 97 | 95 | 91 |
| Other Current Assets, Total | 23 | 21 | 37 | 32 | 10 |
| Total Assets | 1611 | 1671 | 1700 | 1832 | 1724 |
| Property/Plant/Equipment, Total - Net | 100 | 99 | 95 | 95 | 90 |
| Intangibles, Net | 60 | 88 | 84 | 82 | 78 |
| Note Receivable - Long Term | 82 | 82 | 82 | 84 | 82 |
| Other Long Term Assets, Total | 102 | 110 | 125 | 127 | 126 |
| Total Current Liabilities | 656 | 633 | 712 | 804 | 728 |
| Accounts Payable | 25 | 27 | 33 | 137 | 64 |
| Accrued Expenses | 504 | 500 | 517 | 583 | 579 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 12 | 11 | 11 | 11 | 11 |
| Other Current Liabilities, Total | 115 | 95 | 151 | 73 | 74 |
| Total Liabilities | 1447 | 1438 | 1539 | 1629 | 1492 |
| Total Long Term Debt | 270 | 279 | 277 | 275 | 271 |
| Long Term Debt | 229 | 239 | 239 | 239 | 238 |
| Capital Lease Obligations | 41 | 40 | 38 | 36 | 33 |
| Other Liabilities, Total | 521 | 526 | 550 | 550 | 493 |
| Total Equity | 164 | 233 | 161 | 203 | 232 |
| Common Stock | 73 | 73 | 72 | 70 | 71 |
| Additional Paid-In Capital | 6 | 6 | 7 | 7 | 7 |
| Retained Earnings (Accumulated Deficit) | 97 | 165 | 101 | 146 | 180 |
| Other Equity, Total | -12 | -11 | -19 | -20 | -26 |
| Total Liabilities & Shareholders’ Equity | 1611 | 1671 | 1700 | 1832 | 1724 |
| Total Common Shares Outstanding | 732.408 | 734.839 | 733.505 | 702.44 | 706.024 |
| Kratkoročne naložbe | 65 | ||||
| Prepaid Expenses | 15 | ||||
| Long Term Investments | 85 |
- Letni
- Četrtletno
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Čisti prihodki/začetna postavka | 149 | 193 | 292 | 178 | -156 | 213 |
| Denarna sredstva iz poslovanja | 407 | 295 | 303 | 151 | -193 | 353 |
| Denarna sredstva iz poslovanja | 14 | 13 | 40 | 28 | 26 | 22 |
| Nedenarne postavke | 11 | 22 | -34 | 1 | 1 | -21 |
| Cash Taxes Paid | 63 | 33 | 16 | -18 | 34 | 17 |
| Denarna sredstva Plačane obresti | 42 | 36 | 25 | 17 | 20 | 18 |
| Spremembe v obratnem kapitalu | 233 | 67 | 5 | -56 | -64 | 139 |
| Denarna sredstva pri naložbenju | -35 | -43 | -4 | -2 | -4 | -14 |
| Kapitalski izdatki | -35 | -43 | -41 | -7 | -4 | -34 |
| Denarna sredstva pri financiranju | -147 | -84 | -237 | -13 | -10 | -94 |
| Total Cash Dividends Paid | -69 | 0 | ||||
| Izdaja (odplačilo) dolga, neto | -78 | -86 | -240 | -13 | -11 | 6 |
| Učinki deviznih tečajev | 0 | 3 | -1 | 0 | 5 | -1 |
| Neto sprememba denarnih sredstev | 225 | 171 | 61 | 136 | -202 | 244 |
| Izdaja (odplačilo) delnic, neto | 2 | 3 | 0 | 1 | -100 | |
| Celotne druge postavke denarnih tokov pri naložbenju | 37 | 5 | 0 | 20 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 57 | 130 | 168 | 213 | 54 |
| Cash From Operating Activities | 89 | 160 | 186 | 353 | -75 |
| Cash From Operating Activities | 5 | 12 | 18 | 22 | 5 |
| Non-Cash Items | -1 | -8 | -24 | -21 | -8 |
| Cash Taxes Paid | 2 | -17 | -7 | 17 | 2 |
| Cash Interest Paid | 4 | 10 | 14 | 18 | 9 |
| Changes in Working Capital | 28 | 26 | 24 | 139 | -126 |
| Cash From Investing Activities | 1 | -30 | -12 | -14 | -149 |
| Other Investing Cash Flow Items, Total | 1 | 1 | 20 | 20 | -149 |
| Cash From Financing Activities | -3 | 11 | -26 | -94 | -2 |
| Issuance (Retirement) of Stock, Net | 0 | 0 | -34 | -100 | 1 |
| Issuance (Retirement) of Debt, Net | -3 | 11 | 8 | 6 | -3 |
| Net Change in Cash | 87 | 142 | 149 | 244 | -228 |
| Capital Expenditures | -31 | -32 | -34 | ||
| Foreign Exchange Effects | 1 | 1 | -1 | -2 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| Scopia Capital Management LP | Hedge Fund | 9.0035 | 12267363 | -1296708 | 2022-12-22 | MED |
| Kairos Capital Management, LLC | Investment Advisor | 5.5132 | 7511808 | 0 | 2022-03-17 | LOW |
| Société Générale Securities Services S.A. | Research Firm | 4.88 | 6649013 | -400203 | 2023-01-18 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.9485 | 4017387 | 179724 | 2022-11-30 | LOW |
| Morgan Stanley & Co. International Plc | Research Firm | 2.4595 | 3351079 | -1417196 | 2023-01-25 | MED |
| Artemis Investment Management LLP | Investment Advisor/Hedge Fund | 2.2678 | 3089916 | -847315 | 2022-11-26 | MED |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.1011 | 2862785 | 41527 | 2023-01-02 | LOW |
| Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 2.099 | 2859915 | 0 | 2023-01-02 | MED |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.0183 | 2749990 | -17562 | 2023-01-02 | LOW |
| Capital Research Global Investors | Investment Advisor | 1.8473 | 2516920 | 155800 | 2022-11-30 | LOW |
| Liontrust Investment Partners LLP | Investment Advisor | 1.6475 | 2244725 | -222701 | 2022-11-30 | LOW |
| JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 1.5226 | 2074519 | 0 | 2023-01-02 | LOW |
| Aberdeen Standard Investments (Edinburgh) | Investment Advisor | 1.4064 | 1916258 | -210689 | 2023-01-02 | LOW |
| Prelude Capital Management, LLC | Hedge Fund | 1.3423 | 1828853 | 0 | 2022-11-24 | HIGH |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.2981 | 1768698 | 1572 | 2022-11-30 | LOW |
| Newtyn Management, LLC | Hedge Fund | 1.1413 | 1555000 | 0 | 2022-10-31 | MED |
| Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 0.9415 | 1282839 | -3468 | 2023-01-02 | LOW |
| Jupiter Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.9057 | 1234022 | -581502 | 2022-11-26 | LOW |
| Two Seas Capital LP | Hedge Fund | 0.8332 | 1135195 | 167039 | 2022-10-31 | MED |
| Premier Asset Management Ltd | Investment Advisor/Hedge Fund | 0.7585 | 1033439 | -657653 | 2022-11-26 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group +485000+
Borzni posredniki
65000+
Aktivne stranke mesečno
$48000000+
Mesečni obseg naložb
$28000000+
Preizkusi zdaj Dvigi vsak mesec
Kalkulator trgovanja
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trgovalna provizija
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Vzvod
20:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Indivior Company profile
O družbi Indivior PLC
Indivior PLC je farmacevtsko podjetje s sedežem v Združenem kraljestvu. Podjetje se ukvarja z razvojem zdravil za zdravljenje odvisnosti in resnih duševnih bolezni. Osredotoča se na oblikovanje portfelja zdravil za zdravljenje odvisnosti od opioidov. V pripravi ima še vrsto izdelkov, namenjenih zdravljenju drugih kroničnih bolezni in sočasnih motenj odvisnosti, vključno z motnjo uživanja alkohola. Njegov proizvodni program se osredotoča na razvoj in odkrivanje neopioidnih strategij zdravljenja motenj uporabe opioidov (OUD) ter novih terapij za obravnavo potreb ljudi, ki trpijo zaradi motenj uporabe alkohola, stimulansov in konoplje. Njegovi pripravljani izdelki med drugim vključujejo INDV-3000 - selektivni antagonist dopaminskega D3-receptorja, RBP-6000 - injekcija buprenorfina XR, sublingvalni film buprenorfina/naloksona, sublingvalne tablete buprenorfina/naloksona in sublingvalne tablete buprenorfina. Portfelj izdelkov je na voljo v več kot 40 državah.
| Industry: | Proprietary & Advanced Pharmaceuticals |
234 Bath Road
SLOUGH
BERKSHIRE SL1 4EE
GB
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 485.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com